Virios Therapeutics Announces Completion of a $1.7 Million Public Offering of Common Shares to Begin Preparation for Planned Imc-2 Long Coronavirus Phase 2B Research
Virios Therapeutics宣布完成170万美元的普通股公开发行开始为计划中的Imc-2长冠状病毒2B期研究做准备
Virios Therapeutics Announces Completion of a $1.7 Million Public Offering of Common Shares to Begin Preparation for Planned Imc-2 Long Coronavirus Phase 2B Research
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.